Production lines for new lenses will create 100 jobs over the next four years
Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013
Dublin-based drugmaker was urged last year to explore a sale of its prescription business
Announcement by Canadian pharmaceutical company drives its shares up by 13%
Dutch-domiciled US group says it is still fully committed to planned $7.2bn takeover of Sweden’s Meda
What Papa brings to the party is a depth of experience from over 30 years in the business
Dublin-based drugmaker’s chief executive Joe Papa receives additional stock and bonus
CEO Joe Papa and CFOJudy Brown hope to persuade Israeli holders of 10% of company not to accept takeover offer
Offer from Mylan remains valid and capable of acceptance by Perrigo shareholders
Irish pharma company claims Mylan’s $27bn offer overstates potential synergies and makes false claims
Company’s shareholders vote to move forward with mega-merger of pharma groups
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle
Perrigo chief executive Joe Papa and Mylan chairman Robert Coury talking about merger for some time
Company does deal with partner Transition Therapeutics as it separately spends $51m on over-the-counter products in Australia
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices